STING1 and myocardial infarction: STING1, which is a hub molecule in the CDSP pathway, is also an attractive therapeutic target in cardiovascular conditions, including in mouse models of doxorubicin-induced cardiac dysfunction, myocardial infarction, and aortic aneurysm and dissection, among others.35